Cardiovascular risk perception and evidence–practice gaps in Australian general practice

Emma L Heeley, Craig S Anderson, Anushka A Patel, Alan Cass, David P Peiris and John P Chalmers
Med J Aust 2010; 193 (2): . || doi: 10.5694/j.1326-5377.2010.tb03824.x
Published online: 19 July 2010

In reply: We thank Radford for his insightful comments, seasoned with spice from the frontline of primary care. Although guidelines are an accepted part of clinical practice, they are just recommendations and are not without their limitations. Treatments need to be individually tailored according to many factors. Our aim, therefore, was to provide a current snapshot of adherence to cardiovascular guidelines in primary care in Australia.1 It would be naive of us to think that there would be complete adherence to the guidelines in the “real world”. We wished to obtain an overall benchmark figure and, more importantly, identify treatment gaps or disparities in care across important patient subgroups defined by risk of cardiovascular event.

  • The George Institute for International Health, Sydney, NSW.


  • 1. Heeley EL, Peiris DP, Patel AA, et al. Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010; 192: 254-259. <MJA full text>
  • 2. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
  • 3. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
  • 4. Blood Pressure Lowering Treatment Trialists’ Collaboration; Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121-1123.
  • 5. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists’ Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.